Beautiful Virgin Islands

Wednesday, Aug 27, 2025

UK Approves Covid Jab For Under-12s As New Daily Cases Top 1 Lakh

UK Approves Covid Jab For Under-12s As New Daily Cases Top 1 Lakh

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) said it had approved a new lower-dose formulation of the Pfizer-BioNTech shot after finding it was "safe and effective" for children aged five to 11.

British regulators on Wednesday approved Pfizer's Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.

The developments came after the government said it was cutting the isolation period required for positive cases while Wales and Northern Ireland followed Scotland in unveiling new post-Christmas curbs, primarily around hospitality and large events.

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) said it had approved a new lower-dose formulation of the Pfizer-BioNTech shot after finding it was "safe and effective" for children aged five to 11.

MHRA chief executive June Raine said there was "robust evidence to support a positive benefit risk for children in this age group".

The "overwhelming majority" of reported side-effects from the two-shot "age-appropriate" jab related to mild symptoms, such as a sore arm or a flu-like illness, she added.

The Joint Committee on Vaccination and Immunisation, which advises UK health departments on immunisation, said it was now recommending a primary course of the vaccination be offered to some within the age group.

Britain is in the midst of a stepped-up booster campaign, as it tries to minimise the impact of weeks of rising Omicron infections.

On Wednesday the country surpassed 30 million third doses administered as it aims to offer the additional jab to all adults before the end of the year.

Record infections


The variant is now the dominant strain of the virus across the UK -- already one of the hardest hit in Europe, with a death toll of nearly 148,000 -- as daily cases reach record levels.

It announced 106,122 new infections Wednesday, the highest figure since mass testing began in the summer of last year.

Earlier, the government said people who have tested positive can stop self-isolating after seven days instead of 10 if they have taken two negative lateral flow tests.

Amid the skyrocketing case numbers, it could potentially allow many more to join family Christmas celebrations.

Hours later, devolved governments in Cardiff and Belfast announced new curbs from December 26 -- leaving just England with no imminent restrictions unveiled.

In Wales, socialising in pubs, cinemas and restaurants will be limited to groups of six people or less, while mandatory table service and providing contract tracing details will return.

In Northern Ireland, nightclubs will have to close at 8 pm, alongside guidance to limit contacts with different households.

It follows Scotland announcing renewed rules there Tuesday, which also come into force on December 26 for at least three weeks, and cap attendance at outdoor events at 500.

The move means the pandemic has forced the cancellation of Edinburgh's hugely popular New Year's Eve street party for the second successive year.

Antiviral drugs deal


However, UK Prime Minister Boris Johnson has resisted calls to impose stricter rules in England over Christmas.

The embattled leader, reeling from weeks of scandals and setbacks -- plus growing discontent in his own party -- has said he wants more evidence on Omicron's severity and ability to evade vaccines.

Meanwhile his government has signed deals to buy more than 4 million courses of two new antiviral drugs-- Pfizer's ritonavir and US rival Merck/MSD's molnupiravir -- to treat Covid-19.

Molnupiravir, sold as Lagevrio, is part of a national trial run by the University of Oxford that people can join if they have virus symptoms.

Britain was the first country in the world to approve it last month and the authorities will make it available to those at high risk of severe illness, such as people with cancer.

Pfizer's pill, marketed as Paxlovid, has yet to be authorised anywhere in the world.

The company said Tuesday that clinical trials showed it reduced hospital admissions and deaths among at-risk people by almost 90 percent, when taken a few days after symptoms began.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Spotify’s Strange Move: The Feature Nobody Asked For – Returns
Manhunt in Australia: Armed Anti-Government Suspect Kills Police Officers Sent to Arrest Him
China Launches World’s Most Powerful Neutrino Detector
How Beijing-Linked Networks Shape Elections in New York City
Ukrainian Refugee Iryna Zarutska Fled War To US, Stabbed To Death
Elon Musk Sues Apple and OpenAI Over Alleged App Store Monopoly
2 Australian Police Shot Dead In Encounter In Rural Victoria State
Vietnam Evacuates Hundreds of Thousands as Typhoon Kajiki Strikes; China’s Sanya Shuts Down
UK Government Delays Decision on China’s Proposed London Embassy Amid Concerns Over Redacted Plans
A 150-Year Tradition to Be Abolished? Uproar Over the Popular Central Park Attraction
A new faith called Robotheism claims artificial intelligence isn’t just smart but actually God itself
Deputy Prime Minister Angela Rayner Purchases Third Property Amid Housing Tax Reforms Debate
HSBC Switzerland Ends Relationships with Over 1,000 Clients from Saudi Arabia, Lebanon, Qatar, and Egypt
Sharia Law Made Legally Binding in Austria Despite Warnings Over 'Incompatible' Values
Italian Facebook Group Sharing Intimate Images Without Consent Shut Down Amid Police Investigation
Dutch Foreign Minister Resigns Amid Deadlock Over Israel Sanctions
Trump and Allies Send Messages of Support to Ukraine on Independence Day Amid Ongoing Conflict
China Reels as Telegram Chat Group Shares Hidden-Camera Footage of Women and Children
Sam Nicoresti becomes first transgender comedian to win Edinburgh Comedy Award
Builders uncover historic human remains in Lancashire house renovation
Australia Wants to Tax Your Empty Bedrooms
MotoGP Cameraman Narrowly Avoids Pedro Acosta Crash at Hungarian Grand Prix
FBI Investigates John Bolton Over Classified Documents in High-Profile Raids
Report reveals OpenAI pitched national ChatGPT Plus subscription to UK ministers
Labour set to freeze income tax thresholds in long-term 'stealth' tax raid
Coca‑Cola explores sale of Costa coffee chain
Trial hears dog walker was chased and fatally stabbed by trio
Restaurateur resigns from government hospitality council over tax criticism
Spanish City funfair shut after serious ride injury
Suspected arson at Ilford restaurant leaves three in critical condition
Tottenham beat Manchester City to go top of Premier League
Bank holiday heatwave to hit 30°C before remnants of Hurricane Erin arrive
UK to deploy immigration advisers to West Africa to block fake visas
Nurse who raped woman continued working for a year despite police alert
Drought forces closures of England’s canal routes, canceling boat holidays
Sweet tooth scents: food-inspired perfumes surge as weight-loss drugs suppress appetites
Experts warn Britain dangerously reliant on imported food
Family of Notting Hill Carnival murder victim call event unmanageable
Bunkers, Billions and Apocalypse: The Secret Compounds of Zuckerberg and the Tech Giants
Ukraine Declares De Facto War on Hungary and Slovakia with Terror Drone Strikes on Their Gas Lifeline
Animated K-pop Musical ‘KPop Demon Hunters’ Becomes Netflix’s Most-Watched Original Animated Film
New York Appeals Court Voids Nearly $500 Million Civil Fraud Penalty Against Trump While Upholding Fraud Liability
Elon Musk tweeted, “Europe is dying”
Far-Right Activist Convicted of Incitement Changes Gender and Demands: "Send Me to a Women’s Prison" | The Storm in Germany
Hungary Criticizes Ukraine: "Violating Our Sovereignty"
Will this be the first country to return to negative interest rates?
Child-free hotels spark controversy
North Korea is where this 95-year-old wants to die. South Korea won’t let him go. Is this our ally or a human rights enemy?
Hong Kong Launches Regulatory Regime and Trials for HKD-Backed Stablecoins
China rehearses September 3 Victory Day parade as imagery points to ‘loyal wingman’ FH-97 family presence
×